Unified bioinformatics for lab and AI scientists
‘s-Hertogenbosch, The Netherlands, October 1, 2024 – ENPICOM, an innovative bioinformatics software engineering company, announces the launch of its new unified bioinformatics solution designed to accelerate biologics discovery and development. The ENPICOM Platform seamlessly integrates AI, data management, and machine learning (ML) frameworks to foster collaboration among lab scientists, data scientists, and ML experts to drive innovation in biologics research.
“The question is no longer whether AI will change our lives, but how profoundly and rapidly it will do so,” said Nicola Bonzanni, CEO of ENPICOM. “In biologics discovery, AI must be made accessible and embedded directly into the workflows of scientists who make critical decisions. We are excited to bring a solution to the market that enables and streamlines this integration, enabling organizations to leverage AI’s potential fully.”
Key features and benefits:
• ML model accessibility for lab scientists. Lab scientists can now easily integrate machine learning models into their workflows, enabling more precise candidate selection and faster decision-making without requiring deep technical knowledge.
• Powerful discovery tooling. Built for scalability, ENPICOM’s no-code software allows researchers to quickly analyze and navigate complex datasets, accelerating the discovery of biologic candidates and optimizing the drug discovery and development pipeline.
• Simplified machine learning lifecycle. The platform streamlines ML model management, training, and deployment, giving data scientists the infrastructure to develop and refine models while ensuring seamless transitions from experimentation to production.
• Truly unified experience. With a fully integrated ecosystem, teams across departments can collaborate effortlessly, breaking down silos and accelerating AI adoption for lab scientists-all while reducing operational costs and complexity.
The growing opportunity for AI integration in biologics
AI is revolutionizing drug discovery, potentially reducing time-to-market by up to 50% and cutting research and development costs by billions annually. According to industry projections, the global market for AI in drug discovery is expected to grow from $0.9 billion in 2023 to $4.9 billion by 2028 at a compound annual growth rate (CAGR) of 40.2%.
However, the integration of AI into biologics discovery brings its own set of challenges:
• Lab scientists need intuitive and easy-to-use AI tools, without requiring extensive retraining or reliance on data scientists.
• Data scientists must manage large-scale datasets, ensure reproducibility, and maintain continuous integration and deployment pipelines.
• Business stakeholders seek to ensure AI delivers on its promise to drive innovation and operational efficiency by fostering collaboration between lab and data scientists and transitioning their organization from ML experimentation to production-ready models.
Additionally, key milestones must be reached for successful AI integration in biologics. These include designing and implementing a scalable, FAIR data foundation, and consolidating analysis pipelines into a robust, maintainable orchestration architecture that enforces SOPs and facilitates data harmonization.
The ENPICOM team brings over a decade of experience in overcoming these challenges, helping large pharmaceutical organizations reach these milestones. Now, with the launch of the ENPICOM Platform, we are taking the next step. Lab scientists can leverage intuitive interfaces to harness AI’s capabilities, data scientists benefit from scalable infrastructure for AI model management, and business leaders maximize ROI through enhanced collaboration and efficient AI integration across teams.
ENPICOM BV
Sint Janssingel 88
5211DA, ‘s-Hertogenbosch
communications@enpicom.com
About ENPICOM
ENPICOM is an innovative bioinformatics software engineering company committed to accelerating biologics discovery and development through cutting-edge bioinformatics solutions. With a deep understanding of biology, software engineering, and AI, ENPICOM delivers innovative tools that empower scientists to make groundbreaking discoveries faster and more accurately.
For more information about the ENPICOM Platform and how it can transform your biologics research, visit www.enpicom.com.
This release was published on openPR.
